Artixio

Vietnam Pharma Regulatory Services

Pharma Regulatory Affairs Services in Vietnam

In Vietnam, getting a pharma product approved isn’t just about filling forms — it’s about knowing how the system really works. As a trusted regulatory consultant for pharmaceuticals in Vietnam, we help you move through approvals smoothly and confidently.

MoH Pharma Compliance and Representation Services

Working with Vietnam’s Ministry of Health involves more than just filling out forms — it requires knowing how the system works in practice. Artixio serves as your on-ground representative, handling submissions, clarifying requirements, and following up with the right departments. We stay connected with MoH officials, track each step of the process, and make sure your pharmaceutical products meet the exact compliance standards needed for market access in Vietnam.

End-to-End Drug Regulatory Support in Vietnam

Artixio provides complete guidance for pharmaceutical companies entering or expanding in Vietnam. Our role is to simplify complex regulatory steps so you can focus on your core business. We manage every stage, from initial planning to successful product launch, with a hands-on, practical approach that works in the local context.

Our pharma regulatory services include:

  • Product registration with the Ministry of Health (MoH)
  • Dossier preparation and submission
  • Regulatory gap analysis
  • Compliance review and advisory
  • Pharmacovigilance system setup
  • Labeling and packaging compliance checks
  • Market entry strategy support
  • License renewals and variations

Pharmaceutical Market Entry and Compliance Strategy in Vietnam

At Artixio, we plan the path from the very start, helping you avoid delays and unexpected costs.

We look at your product, its category, and the rules that apply. Then we match that with what the Ministry of Health expects — not just on paper, but in practice. Some approvals move faster if your documents are set up in a certain way. Some need extra local data. We make sure you know that upfront.

Our role is to keep you on the right side of the law while positioning your product for a smooth launch. You focus on building the brand; we handle the compliance grind — applications, follow-ups, translations, local representation, the lot.

Specialized Regulatory Consulting for Pharma in Vietnam

 Our team works as your in-country regulatory partner, translating Vietnam’s complex rules into clear, actionable steps for faster approvals.

What gives our pharma clients in Vietnam an edge:

  • Product Classification Guidance
  • Regulatory Pathway Assessment
  • Labeling & Packaging Compliance
  • Post-Approval Variations Management
  • Liaison with Vietnam MoH Authorities
  • Dossier Review & Submission Support

Our Regulatory Services in Vietnam

Regulatory Affairs
Product Registration
Market Access
IND (Investigational New Drug)
NDA (New Drug Application)
Regulatory Operations
Technical Writing
Regulatory Strategy
Market Access

Why Trust Us For Pharma Regulatory Consulting In Vietnam?

20+ years working with Vietnam’s Drug Administration (DAV)
Full regulatory lifecycle support — from dossier preparation to post-approval changes
Precise, compliant submission of drug registration dossiers
Local representation to manage Ministry of Health approvals directly
Proven track record of shortening approval timelines
5,000+ pharmaceutical product registrations completed successfully

FAQs

How long does it take to register a pharmaceutical product in Vietnam?

On average, it can take 12–18 months depending on the product type, dossier completeness, and Drug Administration of Vietnam (DAV) review timelines.

Yes. The Ministry of Health requires foreign manufacturers to appoint a licensed local representative for regulatory submissions and compliance activities.

General requirements include a legalized Certificate of Pharmaceutical Product (CPP), GMP certificate, product dossier (CTD format), stability data, and labeling in Vietnamese.

Yes. Variations must be submitted to the DAV for approval, with timelines and requirements depending on the change type (major or minor).

Yes. While both follow DAV’s registration framework, OTC drugs often have simplified data requirements compared to prescription medicines.

Industries We Serve in the Vietnam

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Our Global Reach: Serving Life
Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Thai FDA Updates Medical Device Advertising Rules – Jan, 2025

Thai FDA Updates Medical

The Food and Drug Administration Announcement RE: Determination of Criteria, Conditions, and Requirements for...

August 12, 2025
Companion Diagnostics Regulations In Australia

Companion Diagnostics Regulations In

A Companion Diagnostic (CDx) is an in-vitro diagnostic (IVD) medical device that plays a...

August 11, 2025
CDSCO Medical Device Approval Cost & Fee Structure

CDSCO Medical Device Approval

Central Drug Standard Control Organization (CDSCO) is the regulatory authority that regulates Medical Devices...

July 29, 2025